Neovasc's Tiara™ Mitral Valve Replacement Technology Featured in Update Presentation at the CRT 2019 Meeting

[In The News]

NASDAQ, TSX: NVCN VANCOUVER, March 4, 2019 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the ...

View the full article